Cardiovascular Outcome of the SGLT2 Inhibitor in Acute Myocardial Infarction: A Meta-Analysis
Background: Unexpected cardiovascular events are likely to occur within a short period following an acute myocardial infarction (AMI). The sodium-glucose co-transporter 2 inhibitor (SGLT2-I) is a recently recommended drug for the treatment of AMI. However, its role in the risk of...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
IMR Press
2025-02-01
|
| Reeks: | Reviews in Cardiovascular Medicine |
| Onderwerpen: | |
| Online toegang: | https://www.imrpress.com/journal/RCM/26/2/10.31083/RCM26136 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|